Soucasné moznosti diagnostiky a lécby zenské androgenetické alopecie
[Contemporary alternatives in the diagnostics and therapy of female androgenetic alopecia]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article, Review
PubMed
16634476
- MeSH
- Alopecia diagnosis drug therapy MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Review MeSH
Female androgenetic alopecia belongs to the family of scar-less, diffuse, telogenic, hormonally determined alopecias with hereditary disposition. In the androgenetic alopecia, progressive, androgen mediated miniaturization of genetically predestined hair follicles develops. Genetic factors play a role namely in females without the higher serum androgen level. Pathologically high level of serum androgens is usually accompanied with signs of virilization. Hair dropping starts in the fourth decade or earlier. It occurs in the postmenopausal period, after a pregnancy, after the onset or termination of peroral contraception, in women treated by aromatase inhibitors.